164 related articles for article (PubMed ID: 35339454)
1. Effect of aberrant DNA methylation on cancer stem cell properties.
Mazloumi Z; Farahzadi R; Rafat A; Dizaji Asl K; Karimipour M; Montazer M; Movassaghpour AA; Dehnad A; Nozad Charoudeh H
Exp Mol Pathol; 2022 Apr; 125():104757. PubMed ID: 35339454
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic approach of Cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy.
Norollahi SE; Mansour-Ghanaei F; Joukar F; Ghadarjani S; Mojtahedi K; Gharaei Nejad K; Hemmati H; Gharibpoor F; Khaksar R; Samadani AA
Biomed Pharmacother; 2019 Jul; 115():108958. PubMed ID: 31075731
[TBL] [Abstract][Full Text] [Related]
3. The dynamics and prognostic potential of DNA methylation changes at stem cell gene loci in women's cancer.
Zhuang J; Jones A; Lee SH; Ng E; Fiegl H; Zikan M; Cibula D; Sargent A; Salvesen HB; Jacobs IJ; Kitchener HC; Teschendorff AE; Widschwendter M
PLoS Genet; 2012 Feb; 8(2):e1002517. PubMed ID: 22346766
[TBL] [Abstract][Full Text] [Related]
4. The role of epigenetic transcription repression and DNA methyltransferases in cancer.
Daniel FI; Cherubini K; Yurgel LS; de Figueiredo MA; Salum FG
Cancer; 2011 Feb; 117(4):677-87. PubMed ID: 20945317
[TBL] [Abstract][Full Text] [Related]
5. Loss of insulin-like growth factor II imprinting is a hallmark associated with enhanced chemo/radiotherapy resistance in cancer stem cells.
Zhao X; Liu X; Wang G; Wen X; Zhang X; Hoffman AR; Li W; Hu JF; Cui J
Oncotarget; 2016 Aug; 7(32):51349-51364. PubMed ID: 27275535
[TBL] [Abstract][Full Text] [Related]
6. An integrated epigenomic-transcriptomic landscape of lung cancer reveals novel methylation driver genes of diagnostic and therapeutic relevance.
Sun X; Yi J; Yang J; Han Y; Qian X; Liu Y; Li J; Lu B; Zhang J; Pan X; Liu Y; Liang M; Chen E; Liu P; Lu Y
Theranostics; 2021; 11(11):5346-5364. PubMed ID: 33859751
[No Abstract] [Full Text] [Related]
7. HOXC8 regulates self-renewal, differentiation and transformation of breast cancer stem cells.
Shah M; Cardenas R; Wang B; Persson J; Mongan NP; Grabowska A; Allegrucci C
Mol Cancer; 2017 Feb; 16(1):38. PubMed ID: 28202042
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic alterations involved in cancer stem cell reprogramming.
Muñoz P; Iliou MS; Esteller M
Mol Oncol; 2012 Dec; 6(6):620-36. PubMed ID: 23141800
[TBL] [Abstract][Full Text] [Related]
9. The Role of Stem Cell DNA Methylation in Colorectal Carcinogenesis.
Song L; Li Y
Stem Cell Rev Rep; 2016 Oct; 12(5):573-583. PubMed ID: 27402365
[TBL] [Abstract][Full Text] [Related]
10. Combination therapy with epigenetic-targeted and chemotherapeutic drugs delivered by nanoparticles to enhance the chemotherapy response and overcome resistance by breast cancer stem cells.
Li SY; Sun R; Wang HX; Shen S; Liu Y; Du XJ; Zhu YH; Jun W
J Control Release; 2015 May; 205():7-14. PubMed ID: 25445694
[TBL] [Abstract][Full Text] [Related]
11. Distinct epigenetic regulation of tumor suppressor genes in putative cancer stem cells of solid tumors.
Yasuda H; Soejima K; Watanabe H; Kawada I; Nakachi I; Yoda S; Nakayama S; Satomi R; Ikemura S; Terai H; Sato T; Suzuki S; Matsuzaki Y; Naoki K; Ishizaka A
Int J Oncol; 2010 Dec; 37(6):1537-46. PubMed ID: 21042723
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA alterations and associated aberrant DNA methylation patterns across multiple sample types in oral squamous cell carcinoma.
Wiklund ED; Gao S; Hulf T; Sibbritt T; Nair S; Costea DE; Villadsen SB; Bakholdt V; Bramsen JB; Sørensen JA; Krogdahl A; Clark SJ; Kjems J
PLoS One; 2011; 6(11):e27840. PubMed ID: 22132151
[TBL] [Abstract][Full Text] [Related]
13. DNA hypomethylation and activation of germline-specific genes in cancer.
De Smet C; Loriot A
Adv Exp Med Biol; 2013; 754():149-66. PubMed ID: 22956500
[TBL] [Abstract][Full Text] [Related]
14. Brief reports: A distinct DNA methylation signature defines breast cancer stem cells and predicts cancer outcome.
El Helou R; Wicinski J; Guille A; Adélaïde J; Finetti P; Bertucci F; Chaffanet M; Birnbaum D; Charafe-Jauffret E; Ginestier C
Stem Cells; 2014 Nov; 32(11):3031-6. PubMed ID: 25069843
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic regulation of cancer stem cell gene expression.
Bapat SA
Subcell Biochem; 2013; 61():419-34. PubMed ID: 23150261
[TBL] [Abstract][Full Text] [Related]
16. Revealing role of epigenetic modifiers and DNA oxidation in cell-autonomous regulation of Cancer stem cells.
Ferrer-Diaz AI; Sinha G; Petryna A; Gonzalez-Bermejo R; Kenfack Y; Adetayo O; Patel SA; Hooda-Nehra A; Rameshwar P
Cell Commun Signal; 2024 Feb; 22(1):119. PubMed ID: 38347590
[TBL] [Abstract][Full Text] [Related]
17. Activation of Matrix Hyaluronan-Mediated CD44 Signaling, Epigenetic Regulation and Chemoresistance in Head and Neck Cancer Stem Cells.
Bourguignon LYW; Earle C; Shiina M
Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28837080
[TBL] [Abstract][Full Text] [Related]
18. Homeobox gene Rhox5 is regulated by epigenetic mechanisms in cancer and stem cells and promotes cancer growth.
Li Q; O'Malley ME; Bartlett DL; Guo ZS
Mol Cancer; 2011 May; 10():63. PubMed ID: 21609483
[TBL] [Abstract][Full Text] [Related]
19. Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma.
Kurscheid S; Bady P; Sciuscio D; Samarzija I; Shay T; Vassallo I; Criekinge WV; Daniel RT; van den Bent MJ; Marosi C; Weller M; Mason WP; Domany E; Stupp R; Delorenzi M; Hegi ME
Genome Biol; 2015 Jan; 16(1):16. PubMed ID: 25622821
[TBL] [Abstract][Full Text] [Related]
20. DNA hypomethylation in cancer cells.
Ehrlich M
Epigenomics; 2009 Dec; 1(2):239-59. PubMed ID: 20495664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]